Please login to the form below
Ursula von der Leyen
This page shows the latest Ursula von der Leyen news and features for those working in and with pharma, biotech and healthcare.
Court rules on AZ and EU’s COVID-19 vaccine dispute
The EC has claimed the ruling as a victory, with Commission president Ursula von der Leyen commenting that the “decision confirms the position of the Commission: AstraZeneca did not live up
Latest news
-
EU may seek legal action against AstraZeneca following vaccine supply cuts
We have to and want to explain to our European citizens that they [will] get their fair share,” said Ursula von der Leyen, EC president, at a news conference in March.
-
UPDATE: AZ/Oxford University COVID-19 vaccine gets EU approval
European Commission president Ursula von der Leyen announced yesterday that AZ will deliver nine million additional doses of the vaccine in the first quarter, with 40 million doses in total now ... However, the EU has since reversed these efforts, with
-
EU leaders debate COVID-19 vaccine export measures during virtual summit
During a press conference following the summit, European Commission president Ursula von der Leyen focused on AstraZeneca (AZ), warning the company to ‘honour’ its contract with the EU before exporting vaccine ... That shows that Europe is the region
-
EU, UK working towards a ‘win-win’ situation to expand COVID-19 vaccine supplies
The proposed export plans were announced by the EC’s president Ursula von der Leyen last week, who warned that the EU may halt exports to countries with ‘higher vaccination rates’ ... Von der Leyen added that she wants “to see reciprocity and
-
EU-UK COVID-19 vaccine row continues as export ban discussion looms
Last week, the European Commission’s (EC) president Ursula von der Leyen warned that the EU may halt exports to countries with ‘higher vaccination rates’ if supplies to the EU do ... Von der Leyen added that she wants “to see reciprocity and
EU may seek legal action against AstraZeneca following vaccine supply cuts
UPDATE: AZ/Oxford University COVID-19 vaccine gets EU approval
EU leaders debate COVID-19 vaccine export measures during virtual summit
EU, UK working towards a ‘win-win’ situation to expand COVID-19 vaccine supplies
EU-UK COVID-19 vaccine row continues as export ban discussion looms
More from news
Approximately 1 fully matching, plus 23 partially matching documents found.
Latest from PMHub
-
It's out - so what?
Let us not forget, Health Commissioner Stella Kyriakides, Vice-President Margaritis Schinas and President Ursula von der Leyen all hail from the EPP.
-
What is everyone ‘ARPAing on about?
On Wednesday 16th September, Ursula Von Der Leyen, President of the European Union, announced in her State of Union address that they plan to develop BARDA, a Biomedical Advanced Research and
-
Hanover Communications
On Wednesday 16th September, Ursula Von Der Leyen, President of the European Union, announced in her State of Union address that they plan to develop BARDA, a Biomedical Advanced Research and
Hanover Communications
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Events Executive
-
Depending on Experience
- Project Director, Healthcare Marketing Agency patient focus Lond...
-
Highly competitive salary
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
-
Digital account director
-
Competitive
- Senior Consultant, Pricing & Market Access Consultancy, circ...
-
circa £100K package
- Digital Project Director, Healthcare Marketing Agency patient fo...
-
Highly competitive salary
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- CHMP rejects Kyowa Kirin’s Parkinson’s disease drug
- Google’s DeepMind opens ‘breakthrough’ protein database to the world
- Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels
- Blockchain for Tracking and Validating Medical Cannabis
- Improving Health Through Integrated & Personalized Patient Care
- Amanda Pritchard becomes NHS England’s first female chief executive
- GSK beats expectations thanks to strong vaccine sales in Q2
- AZ raises full-year guidance after completing Alexion acquisition in Q2
- Resilience acquires bluebird bio’s manufacturing facility as part of cell therapy alliance
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Roche engaged in talks with FDA for Alzheimer’s drug candidate
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
- Pharma’s authentic proof of purpose influences decisions among HCPs and payers
- Tyson Fury takes on his Invisible Opponent in hard hitting ad for suicide prevention charity Campaign Against Living Miserably
- What do NHS changes and the Life Sciences Vision mean for medicines?
PMHub
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...
Latest intelligence
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
- Employee wellbeing in creative agencies: three tips to get you started
- Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
- Managing unhelpful pressure in your creative agency: the human approach
- Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...
